{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:27:28Z","timestamp":1793068048515,"version":"4.5.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamapsychiatry.2020.1035","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T11:43:16Z","timestamp":1590579796000},"page":"1044","source":"Crossref","is-referenced-by-count":193,"title":["Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence"],"prefix":"10.1001","volume":"77","author":[{"given":"Lindsey A.","family":"Hines","sequence":"first","affiliation":[{"name":"Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath, United Kingdom"},{"name":"Institute of Psychiatry, Psychology & Neuroscience, National Addiction Centre, London, United Kingdom"},{"name":"Clinical Psychopharmacology Unit, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne H.","family":"Gage","sequence":"additional","affiliation":[{"name":"Addiction Group, Department of Psychological Sciences, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Zammit","sequence":"additional","affiliation":[{"name":"Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom"},{"name":"Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cannon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Munafo","sequence":"additional","affiliation":[{"name":"Experimental Psychology, University of Bristol School of Psychological Science, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"MacLeod","sequence":"additional","affiliation":[{"name":"Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Heron","sequence":"additional","affiliation":[{"name":"Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"yoi200026r2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S2215-0366(16)30071-2","article-title":"Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA.","volume":"3","author":"Hall","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"yoi200026r3","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi200026r4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874473711205010032","article-title":"Increasing delta-9-tetrahydrocannabinol (?-9-THC) content in herbal cannabis over time: systematic review and meta-analysis.","volume":"5","author":"Cascini","year":"2012","journal-title":"Curr Drug Abuse Rev"},{"issue":"4","key":"yoi200026r5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/dta.2368","article-title":"Potency of ?9-tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: implications for public health and pharmacology.","volume":"10","author":"Potter","year":"2018","journal-title":"Drug Test Anal"},{"issue":"6","key":"yoi200026r6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/add.14525","article-title":"Increasing potency and price of cannabis in Europe, 2006-16.","volume":"114","author":"Freeman","year":"2019","journal-title":"Addiction"},{"issue":"9584","key":"yoi200026r7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"yoi200026r8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamapsychiatry.2018.4500","article-title":"Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis.","volume":"76","author":"Gobbi","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi200026r9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.","volume":"2","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"yoi200026r10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"yoi200026r11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.drugalcdep.2017.04.014","article-title":"User characteristics and effect profile of butane hash oil: an extremely high-potency cannabis concentrate.","volume":"178","author":"Chan","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"15","key":"yoi200026r12","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1017\/S0033291715001178","article-title":"Examining the profile of high-potency cannabis and its association with severity of cannabis dependence.","volume":"45","author":"Freeman","year":"2015","journal-title":"Psychol Med"},{"issue":"1","key":"yoi200026r13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ije\/dys066","article-title":"Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort.","volume":"42","author":"Fraser","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"1","key":"yoi200026r14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ije\/dys064","article-title":"Cohort profile: the \u201cchildren of the 90s\u201d\u2014the index offspring of the Avon Longitudinal Study of Parents and Children.","volume":"42","author":"Boyd","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"10","key":"yoi200026r15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/add.12634","article-title":"Just say \u201cknow\u201d: how do cannabinoid concentrations influence users\u2019 estimates of cannabis potency and the amount they roll in joints?","volume":"109","author":"Freeman","year":"2014","journal-title":"Addiction"},{"key":"yoi200026r16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14659890701476532","article-title":"Validation of the CAST, a general population cannabis abuse screening test.","volume":"12","author":"Legleye","year":"2007","journal-title":"J Subst Use"},{"issue":"9","key":"yoi200026r17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire.","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"issue":"2","key":"yoi200026r19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S0033291700030415","article-title":"Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers.","volume":"22","author":"Lewis","year":"1992","journal-title":"Psychol Med"},{"issue":"1-3","key":"yoi200026r21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.schres.2008.04.036","article-title":"Investigating if psychosis-like symptoms (PLIKS) are associated with family history of schizophrenia or paternal age in the ALSPAC birth cohort.","volume":"104","author":"Zammit","year":"2008","journal-title":"Schizophr Res"},{"issue":"4","key":"yoi200026r22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1176\/appi.ajp.2019.19060654","article-title":"A population-based cohort study examining the incidence and impact of psychotic experiences from childhood to adulthood, and prediction of psychotic disorder.","volume":"177","author":"Sullivan","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"4","key":"yoi200026r24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"5","key":"yoi200026r25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2215-0366(15)00108-X","article-title":"Cannabis and psychosis.","volume":"2","author":"Gage","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"16","key":"yoi200026r26","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1017\/S0033291718000478","article-title":"Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design.","volume":"48","author":"Hines","year":"2018","journal-title":"Psychol Med"},{"key":"yoi200026r18","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"yoi200026r20","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000","edition":"4th ed, text re"},{"key":"yoi200026r23","volume-title":"Mood and Feelings Questionnaire (MFQ)","author":"Angold","year":"1987"},{"key":"yoi200026r1","unstructured":"United Nations Office on Drugs and Crime. World drug report 2016. Accessed April 16, 2020. https:\/\/www.unodc.org\/wdr2016\/"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2765973\/jamapsychiatry_hines_2020_oi_200026_1601309834.63439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T11:18:36Z","timestamp":1602069516000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2765973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1035","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}